Skip to content

Extracorporeal Membrane Oxygenation Physical Training

A Pilot Randomised Controlled Trial in Extracorporeal Membrane Oxygenation Physical Training (ECMO-PT)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03328767
Acronym
ECMO-PT
Enrollment
20
Registered
2017-11-01
Start date
2018-02-19
Completion date
2020-05-01
Last updated
2020-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill, Mechanically Ventilated, Extracorporeal Membrane Oxygenation Complication

Brief summary

Critically ill patients who require extracorporeal membrane oxygenation (ECMO) are the sickest in the hospital. More patients are surviving but survivors have compromised functional recovery for months or years. This trial aims to determine if early, physical training commenced within 48 hours of ECMO is feasible and improves muscle strength and functional status in patients compared to standard practice in a randomised controlled trial of 30 ICU patients.

Detailed description

The use of extracorporeal membrane oxygenation (ECMO) has expanded dramatically in Australia and globally. While life-saving in the short-term, it is typically associated with prolonged immobility and inflammation, which contributes to severe muscle weakness and wasting. Standard care delivers minimal physical training while patients remain on ECMO because standard care prioritises concerns about catheter dislodgement and cardio-respiratory strain. However, in other intensive care unit (ICU) conditions, techniques have been developed to allow early physical training in patients previously thought too unstable to be exercised, with important patient-centred and long-term cost-saving benefits. Our preliminary work shows that early individualised physical training is safe in ICU patients. A multicentre pilot study to establish feasibility in ECMO patients is urgently needed. The primary aim is to test the hypothesis that early, individualised, physical training (commenced within first 48 hours of ECMO) is feasible and improves functional recovery (the highest level of activity and duration). This has previously been reported to be associated with improved independent function at hospital discharge and discharge to home.1 The secondary aims are to test the hypothesis that early individualised physical training is (i) safe; (ii) improves muscle strength at day 7 and 10 and 20; and (iii) improves functional status (IMS) at day 7, 10 and 20 in ECMO patients relative to standard care. We are also aiming to describe the acute physiological effects of early physical training (commenced within 48hours of ECMO initiation) Respiratory and haemodynamic parameters, along with ECMO settings, will be recorded 30 minutes prior to each physical training session, during the session and 30 minutes post the training session. In addition, the range of values (min to max) for these parameters will be recorded for each 24hour period over the 7 days.

Interventions

The early activity and mobilisation intervention is comprised of exercises based on a reproducible, physiological approach using both strength and functional activities

Sponsors

Toronto General Hospital
CollaboratorOTHER
Monash University
CollaboratorOTHER
The Alfred
CollaboratorOTHER
Royal Prince Alfred Hospital, Sydney, Australia
CollaboratorOTHER
The Prince Charles Hospital
CollaboratorOTHER_GOV
St Vincent's Hospital, Sydney
CollaboratorOTHER
Australian and New Zealand Intensive Care Research Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

A 30 patient, multicentre, randomised, trial of early individualised physical training compared to standard care.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* adults ≥ 18 years of age * were physically independent prior to the current admission; * receiving ECMO (veno-arterial or veno-venous) for at least 24 hours; * clinician in charge of patient care has no objection to randomisation

Exclusion criteria

* have been in ICU \> 5 days prior to the commencement of ECMO; * have received ECMO for more than 48 hours; * in the opinion of the treating clinician, is not expected to recover in 90 days (e.g. intracerebral haemorrhage); * whom death is expected within 24 hours; * are unable to communicate in English

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of delivering the intervention in the first 7 days after randomisation and the separation between the groups7 daysFeasibility of delivering the intervention in the first 7 days after randomisation and the separation between the groups using the ICU mobility scale to report the highest level of activity. It is reported as median (IQR) over 7 days.

Secondary

MeasureTime frameDescription
Incidence of Treatment-Emergent Adverse Events, Safety events (including decannulation of ventilator or ECMO cannula, fall to the floor during mobilization, desaturation SpO2 < 85%) at anytime during the first 7 daysDuring the first 7 daysIncidence of Treatment-Emergent Adverse Events, Safety events (including decannulation of ventilator or ECMO cannula, fall to the floor during mobilization, desaturation SpO2 \< 85%) at anytime during the first 7 days
Strength at day 7 and 10Days 7 & 10Strength at day 7 and 10
Time to first stand out of bedWithin the first 28 daysTime to first stand out of bed (within the first 28 days)
ICU and hospital length of stayTime from ICU admission to ICU and hospital discharge respectively censored at day 90ICU and hospital length of stay (time from ICU admission to ICU and hospital discharge respectively censored at day 90)
ICU and in-hospital mortalityTime from ICU admission to ICU and hospital discharge respectively censored at day 90ICU and in-hospital mortality (time from ICU admission to ICU and hospital discharge respectively censored at day 90)
Function (reported as ICU mobility scale) measured at days 7, 10 and 20Days 7, 10 & 20Function (reported as ICU mobility scale) measured at days 7, 10 and 20

Countries

Australia, Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026